Latest filing published 23 Sept 2019 for Adamas Pharmaceuticals Inc, €9,907.
Filing timeline
BuySaleInsider track record
Alfred G. Merriweather: trading record in brief
Alfred G. Merriweather discloses dealings in 2 companies, chiefly Adamas Pharmaceuticals Inc and Celera Corp. In total, 9 filings cover trades dated from 3 January 2011 to 20 September 2019.
The open-market record consists of 3 sales worth €43k, with no purchase. The rest of the record consists of 5 share grants. Since January 2019: no purchases and 2 sales on the market.
The latest filing, published on 23 September 2019, reports an open-market sale of €9,907 in Adamas Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Alfred G. Merriweather
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,584 shares@ US$6.9123.0% of flowCommon StockSEC:0001209191-19-050455:0
- 25,000 shares0Common StockSEC:0001209191-19-024239:0
- 857 shares@ US$7.9914.0% of flowCommon StockSEC:0001209191-19-020792:0
- 1,665 shares@ US$19.1863.0% of flowCommon StockSEC:0001209191-18-051991:0
- 8,375 shares0Common StockSEC:0001209191-18-018672:0
- 18,750 shares0Common StockSEC:0001209191-17-044648:0
- 15,828 shares@ US$8.00Common StockSEC:0001181431-11-029456:0
- 9,172 shares@ US$8.00Common StockSEC:0001181431-11-027982:0
- 25,000 shares0Common StockSEC:0001181431-11-001089:0
9 of 9 declarations
